33 results
8-K
EX-1.1
INZY
Inozyme Pharma Inc
28 Jul 23
Inozyme Pharma, Inc. Announces Pricing of Public Offering of Common Stock
5:19pm
Retirement Income Security Act of 1974, as amended, and the regulations and published interpretations promulgated thereunder (collectively, “ERISA … the Company nor any of its subsidiaries have any “accumulated post-retirement benefit obligations” (within the meaning of Statement of Financial Accounting
8-K
EX-10.1
3tzs9028vrpgv0y7p0tv
8 Dec 22
Departure of Directors or Certain Officers
4:14pm
8-K
EX-1.1
6cu23k2
19 Apr 22
Inozyme Pharma Announces $73 Million Underwritten Offering Priced At-the-Market
7:30am
S-3
EX-1.2
oex32ok40m68e bbpggl
11 Aug 21
Shelf registration
7:12am
S-3
EX-4.4
zozidurbfyfs x7vd
11 Aug 21
Shelf registration
7:12am
S-3
EX-4.3
afgs37ixysxex n4
11 Aug 21
Shelf registration
7:12am
DEF 14A
i6kkwz8opoke0ium y1b
27 Apr 21
Definitive proxy
7:30am
8-K
EX-3.1
yxuoxmmeha
28 Jul 20
Amendments to Articles of Incorporation or Bylaws
4:01pm
424B4
lqz5k78i qapyk8
24 Jul 20
Prospectus supplement with pricing info
4:01pm